We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Moves Forward With Long-Awaited SPL Mandate for Labeling Submissions
FDA Moves Forward With Long-Awaited SPL Mandate for Labeling Submissions
November 1, 2005
After some lengthy delays, the FDA this month will require drugmakers to adopt the structured product labeling (SPL) format for certain human drug labeling submissions, an agency official said.